RU2626979C2 - Трициклические ингибиторы гиразы - Google Patents

Трициклические ингибиторы гиразы Download PDF

Info

Publication number
RU2626979C2
RU2626979C2 RU2013140798A RU2013140798A RU2626979C2 RU 2626979 C2 RU2626979 C2 RU 2626979C2 RU 2013140798 A RU2013140798 A RU 2013140798A RU 2013140798 A RU2013140798 A RU 2013140798A RU 2626979 C2 RU2626979 C2 RU 2626979C2
Authority
RU
Russia
Prior art keywords
compound
optionally substituted
group
amine
alkyl
Prior art date
Application number
RU2013140798A
Other languages
English (en)
Russian (ru)
Other versions
RU2013140798A (ru
Inventor
Дэниел БЕНСЕН
Джон ФИНН
Сак Юнг ЛИ
Чжиюн ЧЭНЬ
Тан То ЛАМ
Сяомин Ли
Майкл ТРЗОСС
Майкл ДЖАНГ
Тоан Б. НГУЕН
Фелис ЛАЙТСТОУН
Лесли Уильям ТАРИ
Цзюнху ЧЖАН
Пол АРИСТОФФ
Дуглас В. ФИЛЛИПСОН
Серджио Е. ВОНГ
Original Assignee
Мерк Шарп Энд Дохме Корп.
Лоуренс Ливермо Нэшнл Секьюрити, Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Шарп Энд Дохме Корп., Лоуренс Ливермо Нэшнл Секьюрити, Ллс filed Critical Мерк Шарп Энд Дохме Корп.
Publication of RU2013140798A publication Critical patent/RU2013140798A/ru
Application granted granted Critical
Publication of RU2626979C2 publication Critical patent/RU2626979C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2013140798A 2011-03-15 2012-03-14 Трициклические ингибиторы гиразы RU2626979C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161453011P 2011-03-15 2011-03-15
US61/453,011 2011-03-15
PCT/US2012/029104 WO2012125746A1 (en) 2011-03-15 2012-03-14 Tricyclic gyrase inhibitors

Publications (2)

Publication Number Publication Date
RU2013140798A RU2013140798A (ru) 2015-04-20
RU2626979C2 true RU2626979C2 (ru) 2017-08-02

Family

ID=45879060

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013140798A RU2626979C2 (ru) 2011-03-15 2012-03-14 Трициклические ингибиторы гиразы

Country Status (16)

Country Link
US (2) US9732083B2 (https=)
EP (1) EP2686320B1 (https=)
JP (1) JP6140083B2 (https=)
KR (2) KR20140059164A (https=)
CN (1) CN103562208B (https=)
AR (1) AR085806A1 (https=)
AU (1) AU2012229997B2 (https=)
BR (1) BR112013023266B8 (https=)
CA (1) CA2829939C (https=)
IL (1) IL228220A (https=)
MX (1) MX345780B (https=)
PH (1) PH12013501800A1 (https=)
RU (1) RU2626979C2 (https=)
TW (1) TWI527818B (https=)
WO (1) WO2012125746A1 (https=)
ZA (1) ZA201307583B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2680138C2 (ru) * 2013-09-11 2019-02-18 Мерк Шарп И Доум Корп. Трициклические ингибиторы гиразы

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686320B1 (en) * 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
EP2807165B1 (en) * 2012-01-27 2019-05-15 Université de Montréal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
CN105189505B (zh) * 2012-09-12 2019-03-22 默克夏普&多梅有限公司 用作抗菌剂的三环促旋酶抑制剂
CN103304488B (zh) * 2013-06-13 2015-12-09 暨明医药科技（苏州）有限公司 光学纯2-（1-羟基乙基）-5-羟基嘧啶的制备方法
US20170007615A1 (en) 2014-02-03 2017-01-12 Biota Europe Ltd Antibacterial Compounds
WO2015150337A1 (en) * 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors
CA3057431A1 (en) 2017-03-24 2018-09-27 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
CN110475777B (zh) * 2017-03-30 2022-04-15 豪夫迈·罗氏有限公司 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物
CN108504647B (zh) * 2018-03-09 2021-11-05 中山大学 一种dna促旋酶的药物结合口袋及其应用
JP7296992B2 (ja) * 2018-05-28 2023-06-23 エフ． ホフマン－ラ ロシュ アーゲー 細菌感染症の処置および予防のための新規オキソキノリジン化合物
WO2020064661A1 (en) * 2018-09-26 2020-04-02 F. Hoffmann-La Roche Ag Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection
EP3887370B1 (en) * 2018-11-27 2023-01-18 F. Hoffmann-La Roche AG Tricyclic compounds for the treatment and prophylaxis of bacterial infection
WO2020109191A1 (en) 2018-11-27 2020-06-04 F. Hoffmann-La Roche Ag Aryl compounds for the treatment and prophylaxis of bacterial infection
WO2020127624A1 (en) 2018-12-20 2020-06-25 F. Hoffmann-La Roche Ag Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infection
CN114763357B (zh) * 2021-01-15 2024-06-18 中国科学院上海药物研究所 吲哚并嘧啶三环类化合物及其制备方法和用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2158127C2 (ru) * 1994-12-23 2000-10-27 Варнер-Ламберт Компани Способы ингибирования тирозинкиназы рецептора эпидермального фактора роста, азотсодержащие трициклические соединения, фармацевтическая композиция, предназначенная для введения ингибитора тирозинкиназы рецептора эпидермального фактора роста, например, erb-b2, erb-b3 или erb-b4, и противозачаточная композиция
EA001428B1 (ru) * 1995-07-06 2001-02-26 Новартис Аг Пирролопиримидины и фармацевтические композиции, включающие эти соединения
WO2003062443A2 (en) * 2001-11-08 2003-07-31 Antex Pharma, Inc. Novel substituted alkane compounds and uses thereof
EP1749822A1 (en) * 2005-08-05 2007-02-07 Hybrigenics S.A. Novel cysteine protease inhibitors and their therapeutic applications
US7326712B2 (en) * 2003-10-14 2008-02-05 Arizona Board Of Regents On Behalf Of The University Of Arizona Substituted tricyclic compounds as protein kinase inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN157280B (https=) 1983-07-15 1986-02-22 Hoechst India
CA1336090C (en) 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
DE4030059A1 (de) 1990-09-22 1992-03-26 Bayer Ag Verfahren zur herstellung von 5-hydroxy-3,4,5,6-tetrahydro-pyrimidin-derivaten
DE4032560A1 (de) 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
ES2150941T3 (es) 1992-04-03 2000-12-16 Upjohn Co Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
US5279359A (en) 1992-06-26 1994-01-18 Erickson Donald C Rotary trisorption heat pump
US5350791A (en) 1992-07-02 1994-09-27 Henkel Corporation Hydrophilicizing treatment for metal objects
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
NZ304519A (en) 1995-03-02 2000-01-28 Upjohn Co Pydrimido[4,5-b]indoles
WO1998029397A1 (en) 1996-12-27 1998-07-09 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrimidine compounds and medicinal use thereof
SI0964865T1 (en) 1997-01-08 2003-08-31 Pharmacia & Upjohn Company Pharmaceutically active tricyclic amines
ATE265847T1 (de) 1997-07-29 2004-05-15 Upjohn Co Selbstemulgierbare formulierung enthaltend lipophile verbindungen
US6147085A (en) 1999-04-01 2000-11-14 Neurogen Corporation Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
EP1068207A1 (en) 1998-04-02 2001-01-17 Neurogen Corporation AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
US6221875B1 (en) 1998-04-02 2001-04-24 Neurogen Corporation Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands
JP2000038350A (ja) 1998-05-18 2000-02-08 Yoshitomi Pharmaceut Ind Ltd 糖尿病治療薬
WO2000066585A1 (en) 1999-04-30 2000-11-09 Neurogen Corporation 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
SK10572002A3 (sk) 2000-01-24 2003-10-07 Warner-Lambert Company 3-Aminochinazolín-2,4-diónové antibakteriálne činidlá
FR2816509B1 (fr) 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
JP2005515173A (ja) 2001-10-31 2005-05-26 バイエル・ヘルスケア・アクチェンゲゼルシャフト ピリミド［４，５−ｂ］インドール誘導体
WO2003057149A2 (en) 2001-12-28 2003-07-17 Bayer Corporation 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
TWI270549B (en) 2002-12-26 2007-01-11 Taisho Pharmaceutical Co Ltd Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
WO2004058764A1 (en) * 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
US20090143399A1 (en) 2003-10-14 2009-06-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US20080051414A1 (en) 2003-10-14 2008-02-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US20090099165A1 (en) 2003-10-14 2009-04-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
JP2006036762A (ja) 2004-06-25 2006-02-09 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
WO2008007113A2 (en) 2006-07-14 2008-01-17 Astex Therapeutics Limited Pharmaceutical combinations
CA2604284A1 (en) 2005-04-28 2006-11-02 Supergen, Inc. Protein kinase inhibitors
US20070049591A1 (en) 2005-08-25 2007-03-01 Kalypsys, Inc. Inhibitors of MAPK/Erk Kinase
JP2007169216A (ja) 2005-12-22 2007-07-05 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
US20080207632A1 (en) 2006-10-31 2008-08-28 Supergen, Inc. Protein kinase inhibitors
US8618121B2 (en) 2007-07-02 2013-12-31 Cancer Research Technology Limited 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US7960400B2 (en) * 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
WO2009091476A1 (en) 2008-01-14 2009-07-23 Irm Llc Compositions and methods for treating cancers
ATE546448T1 (de) * 2008-08-02 2012-03-15 Janssen Pharmaceutica Nv Urotensin-ii-rezeptorantagonisten
WO2011056739A1 (en) 2009-11-03 2011-05-12 Glaxosmithkline Llc Compounds and methods
EP2686320B1 (en) * 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
CN105189505B (zh) * 2012-09-12 2019-03-22 默克夏普&多梅有限公司 用作抗菌剂的三环促旋酶抑制剂
CN105899511B (zh) * 2013-09-11 2019-06-07 默沙东公司 三环促旋酶抑制剂
WO2016067009A1 (en) * 2014-10-28 2016-05-06 Redx Pharma Plc Compounds with activity against bacteria and mycobacteria

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2158127C2 (ru) * 1994-12-23 2000-10-27 Варнер-Ламберт Компани Способы ингибирования тирозинкиназы рецептора эпидермального фактора роста, азотсодержащие трициклические соединения, фармацевтическая композиция, предназначенная для введения ингибитора тирозинкиназы рецептора эпидермального фактора роста, например, erb-b2, erb-b3 или erb-b4, и противозачаточная композиция
EA001428B1 (ru) * 1995-07-06 2001-02-26 Новартис Аг Пирролопиримидины и фармацевтические композиции, включающие эти соединения
WO2003062443A2 (en) * 2001-11-08 2003-07-31 Antex Pharma, Inc. Novel substituted alkane compounds and uses thereof
US7326712B2 (en) * 2003-10-14 2008-02-05 Arizona Board Of Regents On Behalf Of The University Of Arizona Substituted tricyclic compounds as protein kinase inhibitors
EP1749822A1 (en) * 2005-08-05 2007-02-07 Hybrigenics S.A. Novel cysteine protease inhibitors and their therapeutic applications

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
(колонка 81, соединение 32-25; колонка 64, схема 6, соединение 7; колонка 156, схема 14, соединение 22). & 2006/0227992. US 7326712 B2 (MONTIGEN PHARMACEUTICALS INC ), 2008-02-05 (колонка 81, соединение 32-25; колонка 64, схема 3, соединение 7, схема 6, соединение 7, 17; колонка 156, схема 14, соединение 22, 23). & 2006/0227992. WO 03062443 A2 (ANTEX PHARMA INC), 2003-07-31 (схема 2, формула изобретения). US 2009143399 A1 (UNIV ARIZONA), 2009-06-04 (табл. 3, соединение 32-25). RU 2158127 C2 (ВАРНЕР-ЛАМБЕРТ КОМПАНИ), 27.10.2000 (примеры 28, 29). EA 001428 B1 (CIBA GEIGY AG), 2001-02-26 (, формула изобретения). EP1749822 A1 (HYBRIGENICS SA), 2007-02-07 (формула изобретения). *
US 7326712 B2, 2008-02-05 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2680138C2 (ru) * 2013-09-11 2019-02-18 Мерк Шарп И Доум Корп. Трициклические ингибиторы гиразы

Also Published As

Publication number Publication date
WO2012125746A1 (en) 2012-09-20
IL228220A0 (en) 2013-11-25
BR112013023266A8 (pt) 2018-06-12
MX2013010511A (es) 2014-03-27
RU2013140798A (ru) 2015-04-20
IL228220A (en) 2017-04-30
CN103562208B (zh) 2016-08-31
CN103562208A (zh) 2014-02-05
AU2012229997A1 (en) 2013-09-19
EP2686320A1 (en) 2014-01-22
AU2012229997B2 (en) 2016-04-14
MX345780B (es) 2017-02-15
KR102132574B1 (ko) 2020-07-09
EP2686320B1 (en) 2016-05-18
BR112013023266B8 (pt) 2021-04-06
CA2829939C (en) 2020-10-13
NZ614983A (en) 2016-07-29
US10858360B2 (en) 2020-12-08
PH12013501800A1 (en) 2013-10-14
KR20140059164A (ko) 2014-05-15
TWI527818B (zh) 2016-04-01
ZA201307583B (en) 2014-08-27
JP2014508173A (ja) 2014-04-03
BR112013023266B1 (pt) 2020-12-29
US20120238751A1 (en) 2012-09-20
AR085806A1 (es) 2013-10-30
WO2012125746A9 (en) 2013-10-24
BR112013023266A2 (https=) 2017-09-12
TW201245200A (en) 2012-11-16
JP6140083B2 (ja) 2017-05-31
CA2829939A1 (en) 2012-09-20
KR20190104632A (ko) 2019-09-10
US20170369498A1 (en) 2017-12-28
US9732083B2 (en) 2017-08-15

Similar Documents

Publication Publication Date Title
RU2626979C2 (ru) Трициклические ингибиторы гиразы
CN115279763B (zh) Rip1抑制化合物以及制备和使用所述化合物的方法
EP2895488B1 (en) Tricyclic gyrase inhibitors for use as antibacterial agents
AU2013296627C1 (en) Deuterated ibrutinib
AU2020378407B2 (en) Heterocyclic RIP1 inhibitory compounds
KR20220130697A (ko) 새로운 화합물 및 그 용도
AU2016269626B2 (en) Imidazo[1,2-b][1,2,4]triazine derivatives as antiparasitic agents
NZ614983B2 (en) Tricyclic gyrase inhibitors
JPH0834787A (ja) ピロロカルバゾール誘導体及びその製造方法

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant